Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid, Chronic-Phase × lenvatinib × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Neoplasms 8 Carcinoma, Hepatocellular 8 Thyroid Neoplasms 5 Melanoma 5 Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Cancer, Papillary 3 Colorectal Neoplasms 3 Adenocarcinoma, Follicular 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Lymphoma 2 Glioma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, medullary 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 23 Whole-Body Irradiation 22 Peripheral Blood Stem Cell Transplantation 21 Mycophenolic Acid 21 Cyclosporine 18 Busulfan 18 Tacrolimus 15 Imatinib Mesylate 12 Antilymphocyte Serum 12 Methotrexate 11 Melphalan 10 Dasatinib 10 Cord Blood Stem Cell Transplantation 10 Cyclosporins 8 Etoposide 7 nilotinib 6 Radiotherapy 6 Methylprednisolone 6 Filgrastim 6 Sirolimus 5 Alemtuzumab 5 thymoglobulin 4 bosutinib 4 Granulocyte Colony-Stimulating Factor 4 Cytarabine 4 fludarabine 3 Thiotepa 3 Rituximab 3 Flow Cytometry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡